ClinConnect ClinConnect Logo
Search / Trial NCT06458725

Assessment of DW-MRI Measures : Reproducibility and Repeatability in Pelvic Imaging on MR-Linac With Healthy Volunteers

Launched by JULES BORDET INSTITUTE · Jun 12, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Repeatability Reproducibility Mr Linac Radiotherapy Functional Mri

ClinConnect Summary

This clinical trial is looking at a type of MRI called functional MRI to see how reliable it is for measuring conditions in the pelvic area, like rectal and pelvic cancers. The researchers want to find out if they get consistent results when healthy volunteers undergo the MRI multiple times or when different observers look at the results. This information will help improve how we use functional MRI in the future for patients with pelvic diseases.

To be part of this study, participants need to be at least 18 years old and in good health. They should also be able to safely undergo an MRI scan. Unfortunately, people who have had previous radiation treatment to the pelvic area or have certain pelvic health issues cannot join. While the study is still in the planning stages and not yet recruiting participants, those who take part can expect to help researchers learn more about how reliable these MRI measurements are, which could ultimately benefit patients with pelvic cancers.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ≥ 18 yo
  • Healthy
  • Volunteer
  • Ability to undergo an MRI
  • Exclusion Criteria:
  • \< 18yo
  • Contraindication to undergoing an MRI (see safety questionnaire)
  • Previous pelvic irradiation
  • Pelvic pathology

About Jules Bordet Institute

The Jules Bordet Institute is a prestigious cancer research and treatment center located in Brussels, Belgium, dedicated to advancing oncology through innovative clinical trials and multidisciplinary care. As a leading sponsor of clinical research, the institute focuses on developing novel therapeutic approaches and improving patient outcomes in various cancer types. With a commitment to scientific excellence and collaboration, the Jules Bordet Institute leverages cutting-edge technologies and a robust network of healthcare professionals to foster breakthroughs in cancer treatment and enhance the quality of life for patients.

Locations

Patients applied

0 patients applied

Trial Officials

Madeline A Michel, MD

Principal Investigator

Jules Bordet Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported